Pinunta Nittayacharn

This paper develops a nonviral, ultrasound-triggered gene delivery platform using cationic nanobubbles that achieve efficient, site-specific gene expression in vitro and in vivo.

This study evaluates PSMA-targeted nanobubbles in a rabbit model to improve prostate cancer detection via ultrasound, showing enhanced tumor targeting and retention compared to conventional microbubbles.

This paper demonstrates that ultrasound-activated nanobubbles enhance antitumor immunity by restoring extracellular matrix elasticity and re-engaging immune cells in breast cancer models.

This study shows that ultrasound-activated nanobubbles reduce tumor stiffness and enhance lipid nanoparticle delivery and immunotherapy efficacy.

This paper develops three ICG-based nanoprobe platforms to improve NIR-PAI contrast agents by enhancing signal stability and reducing background noise.